Last updated: July 15, 2022
Sponsor: Nanjing Children's Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Liver Disorders
Liver Disease
Gall Bladder Disorders
Treatment
N/AClinical Study ID
NCT05464303
ERBAAC
Ages < 16 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
① Admission time: 2019.01.01-2021.12.31;
② The first diagnosis after discharge was cholangitis
Exclusion
Exclusion Criteria:
① Cholangitis after non-Kasai procedure;
- Postoperative cholangitis of biliary atresia not operated in the unit; ③ Patient hasbeen treated in other hospitals during this episode; ④ The treatment period forcholangitis is not completed or the patient is discharged automatically.
Study Design
Total Participants: 500
Study Start date:
July 15, 2022
Estimated Completion Date:
December 31, 2022
Connect with a study center
NJMU
Nanjing, Jiangsu
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.